BELLICUM PHARMACEUTICALS, INC Uncategorized Contracts & Agreements

15 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of
BELLICUM PHARMACEUTICALS, INC
Biotechnology
2023
Cancer Research Grant Contract, dated July 27, 2011, by and between the Registrant and the Cancer Prevention and Research Institute of Texas
BELLICUM PHARMACEUTICALS, INC
Biotechnology
TX
2020
Omnibus Amendment Agreement, dated October 3, 2014, by and between Registrant and ARIAD Pharmaceuticals, Inc
BELLICUM PHARMACEUTICALS, INC
Biotechnology
NY
2020
Description of Securities
BELLICUM PHARMACEUTICALS, INC
Biotechnology
2020
Open Market Sale AgreementSM, dated October 5, 2018, by and between Bellicum Pharmaceuticals, Inc. and Jefferies LLC
BELLICUM PHARMACEUTICALS, INC
Biotechnology
NY
2018
Cancer Research Grant Contract with the Cancer Prevention and Research Institute of Texas, dated August 9, 2017
BELLICUM PHARMACEUTICALS, INC
Biotechnology
TX
2017
Letter agreement by and between the registrant and Alan A. Musso, effective August 3, 2017
BELLICUM PHARMACEUTICALS, INC
Biotechnology
2017
CO-DEVELOPMENT AND CO-COMMERCIALISATION AGREEMENT BETWEEN ADAPTIMMUNE LIMITED AND BELLICUM PHARMACEUTICALS, INC.
BELLICUM PHARMACEUTICALS, INC
Biotechnology
TX
2017
BELLICUM PHARMACEUTICALS, INC. SPONSORED RESEARCH AGREEMENT NO. 2
BELLICUM PHARMACEUTICALS, INC
Biotechnology
2016
Additional abbreviations may also be used though not in the above list.
BELLICUM PHARMACEUTICALS, INC
Biotechnology
2014
EXCLUSIVELICENSE AGREEMENT Re: BCM BLG # 13-040 Entitled Methods for Inducing Selective Apoptosis
BELLICUM PHARMACEUTICALS, INC
Biotechnology
2014
EXCLUSIVELICENSE AGREEMENT BAYLOR COLLEGE OF MEDICINE BELLICUM PHARMACEUTICALS, INC.
BELLICUM PHARMACEUTICALS, INC
Biotechnology
2014
EXCLUSIVELICENSE AGREEMENT BAYLOR COLLEGE OF MEDICINE BELLICUM PHARMACEUTICALS, INC.
BELLICUM PHARMACEUTICALS, INC
Biotechnology
2014
OMNIBUSAMENDMENT AGREEMENT
BELLICUM PHARMACEUTICALS, INC
Biotechnology
NY
2014
NOTICE OF EXPANSION OF LICENSED FIELD TO OBTAIN ADDITIONAL EXCLUSIVE RIGHTS
BELLICUM PHARMACEUTICALS, INC
Biotechnology
2014